CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
We are very excited to launch our new website! Please take a few moments to click around and explore...
We have now added a new section called the "Assay History List" to the "At A Gla...